Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4,410,025
-
Shares change
-
+1,864,047
-
Total reported value, excl. options
-
$33,425,690
-
Value change
-
+$13,189,492
-
Number of buys
-
28
-
Number of sells
-
-22
-
Price
-
$7.58
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2019
56 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2019.
XBiotech Inc. - Common Shares, no par value (XBIT) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,410,025 shares
of 33,289,095 outstanding shares and own 13.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,193,914 shares), VANGUARD GROUP INC (982,420 shares), BAKER BROS. ADVISORS LP (380,442 shares), Sofinnova Investments, Inc. (331,811 shares), GEODE CAPITAL MANAGEMENT, LLC (297,956 shares), STATE STREET CORP (275,028 shares), Balyasny Asset Management LLC (213,100 shares), NORTHERN TRUST CORP (75,528 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (65,536 shares), and EAM Investors, LLC (61,327 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.